EIF5A and central nervous system cancer: Further, more recent gene expression studies have revealed that glioma-patients with a high expression of eIF-5A have a lower probability of survival, compared to patients with an intermediate expression (National Cancer Institute REMBRANDT database www.caintegrator.nci.nih.gov/rembrandt; p = 0.043; mean of all reporters; Figure S2).